IP Library › Granted Patent US 8,071,332
Granted Patent B2
US 8,071,332 · App. 12/222,412 · Granted Dec 6, 2011

Recombinant mammal cells, method of producing thereof, and method of producing proteins of interest

Assignee: Toto Ltd.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,071,332
App. No.
12/222,412
Granted
Dec 6, 2011
Kind
B2
Abstract

The present invention relates to a method of expressing an objective protein at a high level and stably as well as for a long period even in the absence of a selection drug with a recombinant mammal cell. More particularly, the present invention relates to a method of producing an objective protein by providing a recombinant mammal cell having multiple copies of the exogenous objective protein gene expression unit integrated into a hypoxanthine-phosphoribosyl transferase enzyme (hprt) gene locus and culturing said cell.

Claims (23)

1. A method of producing an objective protein comprising providing a mammal cell having an exogenous objective protein gene integrated into a hypoxanthine-phosphoribosyl transferase enzyme (hprt) gene locus and having a marker gene for gene amplification integrated thereinto wherein the marker gene is glutamine synthetase gene (GS),

subjecting said cell to a condition to cause gene amplification thereby increasing the copy number of the exogenous objective protein gene integrated into the hprt gene locus to obtain a recombinant mammal cell having multiple copies of the exogenous objective protein gene integrated into the hprt gene locus, wherein the condition to cause gene amplification is a process of screening resistance cell in a medium comprising methionine sulfoximine (MSX) as a GS inhibitor and, culturing said cell to produce said objective protein.

2. The method according to claim 1 , wherein said objective protein gene has a copy number of 2 or more.

3. The method according to claim 1 , wherein said objective protein gene is integrated as an expression unit containing at least a promoter sequence and a transcription termination signal sequence into the hprt gene locus.

4. The method according to claim 1 , wherein said objective protein gene or said expression unit is integrated repeatedly in tandem.

5. The method according to claim 1 , wherein a host cell is a cell derived from human.

6. The method according to claim 5 , wherein said host cell is a cell strain HT1080 derived from human fibrosarcoma.

7. The method according to claim 1 , wherein said cell is cultured in the absence of a selecting drug.

8. The method according to claim 1 , wherein the concentration of MSX is stepwise increased.

9. A method of producing a mammal cell in which multiple copies of exogenous protein gene are integrated into the hprt gene locus, comprising providing a cell having the exogenous objective protein gene integrated into the hprt gene locus and having a marker gene for gene amplification integrated thereinto wherein the marker gene is glutamine synthetase gene (GS), and

subjecting said cell to the condition of causing gene amplification to increase the copy number of exogenous objective protein gene integrated into the hprt gene locus wherein the condition of causing gene amplification is a process of screening resistance cell in a medium having added thereto methionine sulfoximine (MSX) as a GS inhibitor.

10. The method according to claim 9 , wherein the concentration of MSX is stepwise increased.

11. A mammal cell in which multiple copies of exogenous protein gene are integrated into the hprt gene locus, the cell being produced by a method comprising

providing a mammal cell having an exogenous objective protein gene integrated into a hypoxanthine-phosphoribosyl transferase enzyme (hprt) gene locus and having a marker gene for gene amplification integrated thereinto wherein the marker gene is glutamine synthetase gene (GS),

subjecting said cell to a condition to cause gene amplification thereby increasing the copy number of the exogenous objective protein gene integrated into the hprt gene locus, wherein the condition to cause gene amplification is a process of screening resistance cell in a medium comprising methionine sulfoximine (MSX) as a GS inhibitor.

12. The cell according to claim 11 , wherein said objective protein gene has a copy number of 2 or more.

13. The cell according to claim 11 , wherein said objective protein gene is integrated as an expression unit containing at least a promoter sequence and a transcription termination signal sequence into the hprt gene locus.

14. The cell according to claim 11 , wherein said objective protein gene or said expression unit is integrated repeatedly in tandem.

15. The cell according to claim 11 , wherein a host cell is a cell derived from human.

16. The cell according to claim 15 , wherein said host cell is a cell strain HT1080 derived from human fibrosarcoma.

17. A method of producing the cell according to claim 11 , comprising a step of integrating multiple copies of exogenous objective protein gene into the hprt gene locus of a host cell.

18. The method according to claim 17 , wherein said objective protein gene is integrated by homologous recombination.

19. The cell according to claim 11 , wherein the concentration of MSX is stepwise increased.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 9, 2008
From: BANZAI, TOSHIAKI; KOYAMA, YUKIKO; SONEZAKI, SHUJI
To: TOTO LTD.
Reel/Frame 021971/0834 →
Priority Claims (2)
JP 2007-210122 · Aug 10, 2007 · national
JP 2008-191278 · Jul 24, 2008 · national
Continuity (2)
Provisional Application 60955738 · Aug 14, 2007
Related Publication 20090117615A1 · May 7, 2009